Study confirms genetic link in cerebral palsy

Emeritus Professor Alastair MacLennan with Mathew Reinersten, from 新浪彩票, who is an ambassador for the group鈥檚 cerebral palsy research
An international research team including the University of 新浪彩票 has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder.
In the study published in the journal researchers employed gene sequencing to examine the DNA of 250 cerebral palsy families, and compared this to a control group of almost 1800 unaffected families. They then demonstrated the impact rare gene mutations can have on movement control using a fruit fly model.
The findings have important clinical implications. They will provide some answers to parents, as well as guide healthcare and family planning such as counselling for recurrence risk 鈥 often quoted as around 1 per cent but could be as high as 10 per cent when factoring in genetic risks.
Co-author of the research, Emeritus Professor Alastair MacLennan, AO, at the University of 新浪彩票, says the new study confirms the pioneering work of the Australian Collaborative Cerebral Palsy Research Group based at the Robinson Research Institute at the University of 新浪彩票.
鈥淐erebral palsy is a non-progressive developmental movement disorder impacting motor function, which affects approximately one in every 700 births in Australia and a similar number worldwide. Symptoms range from mild to severe and can include intellectual disability,鈥 Emeritus Professor MacLennan said.
鈥淗istorically, cerebral palsy was considered largely the result of perinatal asphyxia 鈥 decreased oxygen to the baby鈥檚 brain at birth, however this has only been in found in 8-10 per cent of cases.
鈥淓liminating other known causes, including premature birth and trauma at birth, this leaves a large number of cases 鈥 as many as 40 per cent in some studies 鈥 with an unknown origin.鈥
鈥淎s we come to recognise the role of genetics in cerebral palsy, we open the door for new treatments, earlier diagnosis a